- Home
- DRCT vs KZR Comparison
DRCT vs KZR Comparison
Compare DRCT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- KZR
- Stock Information
- Founded
- DRCT 2018
- KZR 2015
- Country
- DRCT United States
- KZR United States
- Employees
- DRCT N/A
- KZR N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- KZR Health Care
- Exchange
- DRCT Nasdaq
- KZR Nasdaq
- Market Cap
- DRCT 38.7M
- KZR 43.0M
- IPO Year
- DRCT 2022
- KZR 2018
- Fundamental
- Price
- DRCT $1.06
- KZR $6.05
- Analyst Decision
- DRCT Strong Buy
- KZR Hold
- Analyst Count
- DRCT 3
- KZR 2
- Target Price
- DRCT $21.00
- KZR $9.00
- AVG Volume (30 Days)
- DRCT 267.3K
- KZR 26.2K
- Earning Date
- DRCT 03-20-2025
- KZR 03-13-2025
- Dividend Yield
- DRCT N/A
- KZR N/A
- EPS Growth
- DRCT N/A
- KZR N/A
- EPS
- DRCT N/A
- KZR N/A
- Revenue
- DRCT $94,216,000.00
- KZR N/A
- Revenue This Year
- DRCT N/A
- KZR N/A
- Revenue Next Year
- DRCT $37.23
- KZR N/A
- P/E Ratio
- DRCT N/A
- KZR N/A
- Revenue Growth
- DRCT N/A
- KZR N/A
- 52 Week Low
- DRCT $0.51
- KZR $5.20
- 52 Week High
- DRCT $35.88
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- DRCT 41.45
- KZR 43.79
- Support Level
- DRCT $1.10
- KZR $5.86
- Resistance Level
- DRCT $1.18
- KZR $6.57
- Average True Range (ATR)
- DRCT 0.08
- KZR 0.27
- MACD
- DRCT 0.01
- KZR 0.02
- Stochastic Oscillator
- DRCT 10.00
- KZR 25.97
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.